Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 09-2023 | 07-2023 | 06-2023 | 04-2023 | 03-2023 | |
| Operating Expenses | 2,574 | 6,248 | 4,284 | 4,737 | 1,767 |
| Operating Income | -2,574 | -6,248 | -4,284 | -4,737 | -1,767 |
| Interest Expense | 0 | 1,442 | 0 | 1,177 | 0 |
| Other Income | 1,788 | 2,970 | 1,575 | 632 | 1,415 |
| Pre-tax Income | -785 | -4,720 | -2,708 | -5,282 | -352 |
| Net Income Continuous | -785 | -4,720 | -2,708 | -5,282 | -352 |
| Net Income | $-785 | $-4,720 | $-2,708 | $-5,282 | $-352 |
| EPS Basic Total Ops | -0.05 | -8.55 | -0.17 | -9.30 | -0.02 |
| EPS Basic Continuous Ops | -0.25 | -6.73 | -0.86 | -7.61 | -0.11 |
| EPS Diluted Total Ops | -0.05 | -8.55 | -0.17 | -9.30 | -0.02 |
| EPS Diluted Continuous Ops | -0.25 | -6.73 | -0.86 | -7.61 | -0.11 |
| EBITDA(a) | $-2,574 | $-6,205 | $-4,284 | $-4,700 | $-1,767 |